Wednesday, November 13, 2024
10:04 AM EST – Medicenna Therapeutics Corp. : Announced today that it will present pre-clinical data on MDNA11 and IL-2 Superkines in glioblastoma models at the 29th Annual Meeting of the Society of Neuro-Oncology taking place in Houston, Texas from November 21 – 24. Medicenna Therapeutics Corp. (T.MDNA ) shares were up $0.09 at 1.85.
Stocks in Play: Medicenna Therapeutics Corp., Wed, 13 Nov 2024 10:12:06 EST